Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Prognostic relevance of a BPDCN-like immunophenotype in cytogenetically normal AML

Fabio Guolo, MD, of the University of Genoa, Genoa, Italy, outlines the prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like (BPDCN) immunophenotype in cytogenetically normal acute myeloid leukemia (AML) patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).